From D25 to Nirsevimab: A Dutch Discovery that Changed Infant Health WorldwideIn 2007, a breakthrough in respiratory medicine was made in Amsterdam. Prof. Hergen Spits and his team, isolated a potent antibody, D25, from a single immune cell of a Dutch blood donor. This antibody targeted the respiratory syncytial virus (RSV), a common cold virus that poses a serious threat to infants. Today, its optimized successor, nirsevimab, is part of the national immunization program, preventing thousands of hospitalizations each year in the Netherlands and beyond.
Smartwatch use enhances the detection of heart arrythmias, increasing the quality of care.Smartwatches with both PPG and ECG functionality improve the detection of atrial fibrillation in comparison with standard care. Researchers from Amsterdam UMC analysed the data from 437 patients and detected heart arrythmia four times more often in those who wore an Apple Watch. These results are published today in JACC (Journal of the American College of Cardiology).
